Searchable abstracts of presentations at key conferences in endocrinology

ea0016p663 | Signal transduction | ECE2008

Modulation of endothelial NF-κB transcription factors by carbohydrates

Blechmann Rebekka , Neulen Joseph , Motejlek Karin

Objectives: It is well known that compounds of follicular fluid, which is rich in carbohydrates, are able to regulate the expression of angiogenesis-related genes in endothelial cells. Nuclear factor κ B (NF-κB) transcription factors are important candidates in modulating the expression of these genes. The aim of our research is to determine if NF-κB factors are maybe involved in the regulation of endothelial angiogenesis-related genes and thus in ovarian angiog...

ea0021p276 | Pituitary | SFEBES2009

Pituitary gonadotrophinoma and ovarian-hyperfunctioning: link or coincidence?

Raghavan Rajeev , Phillips Suzanne , Bailey Jo , Nelson Richard , Levy Andrew , Bradley Karin

A 40-year-old woman, who had developed oligomenorrhoea after discontinuing the contraceptive pill at age 30, presented with a 6-month history of intermittent vomiting associated with abdominal discomfort and distension. Ultrasound, followed by laparotomy, revealed multiple bilateral ovarian luteal cysts consistent with hyperoestrogenism and ovarian-hyperfunctioning.Only 9 months post-operatively her bilateral theca ovarian cysts had recurred. Over 4 mont...

ea0005s22 | The Adipocyte as an Endocrine Organ | BES2003

Nuclear receptors in metabolic control

Staels B

Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors activated by fatty acids and derivatives. While PPARalpha mediates the hypolipidemic action of fibrates, PPARgamma is the receptor for the antidiabetic glitazones. PPARalpha is highly expressed in tissues such as liver, muscle, kidney and heart, where it stimulates the b-oxidative degradation of fatty acids. PPARgamma is predominantly expressed in adipose tissues, where it promotes adipocyte differentiat...

ea0063p148 | Diabetes, Obesity and Metabolism 1 | ECE2019

Prevalence and risk factors of hepatic steatosis among patients with chronic hepatitis B

Ayari Myriam , Kchir Hella , Cherif Dhouha , Issaoui Dhilel , Maamouri Nadia

Introduction: Chronic hepatitis and NAFLD represent a global public health problem since they are two common cause of chronic liver disease. Hepatic steatosis (HS) is becoming highly prevalent worldwide and its association with hepatitis B, although controversial previously, is increasingly encountered and thought to be related to host factors.Aim and methods: The aim of this retrospective study is to determine the prevalence of HS in chronic hepatitis B...

ea0041gp195 | Thyroid - Basic | ECE2016

Accumulation of PD-1-positve and PD-L1-positve T and B lymphocytes in patients with Graves’ disease

Pyzik Aleksandra , Grywalska Ewelina , Matyjaszek-Matuszek Beata , Kiszczak-Bochynska Ewa , Rolinski Jacek

Introduction: Programmed death-1 (PD-1) is one of the most important inhibitory co-receptors. Studies show that the PD-1/PD-L1 pathway regulates the induction and maintenance of peripheral tolerance and protects tissues from autoimmune attack in physiological conditions. Several studies have shown association of PD-1/PD-L1 pathway with several autoimmune diseases although, to date, no such studies have been performed for Graves’ disease (GD).Aims: T...

ea0014p240 | (1) | ECE2007

Identification of orexin receptors in brown adipocytes: functional effects of orexin-B

Digby Janet , Chen Jing , Markovic Danijela , Viengchareun Say , Lombes Marc , Lehnert Hendrik , Randeva Harpal

Objective: Orexin-A and orexin-B and their G-protein coupled receptors (orexin receptor-1 & -2: OX1R, OX2R) have divergent effects on physiological behaviour, cardiovascular regulation, glucocorticoid and insulin release. Furthermore, orexins have been shown to affect both brown adipose tissue energy expenditure and thermogenesis through stimulation of sympathetic nerve activity. Despite in vivo studies demonstrating a role for orexins acting centrally on adipose ti...

ea0013p174 | Diabetes, metabolism and cardiovascular | SFEBES2007

Identification of orexin receptors in brown adipocytes: functional effects of orexin-B

Digby Janet , Chen Jing , Markovic Danijela , Viengchareun Say , Lombes Marc , Lehnert Hendrik , Randeva Harpal

Objective: Orexin-A and orexin-B and their G-protein coupled receptors (orexin receptor-1 & -2: OX1R, OX2R) have divergent effects on physiological behaviour, cardiovascular regulation, glucocorticoid and insulin release. Furthermore, orexins have been shown to affect both brown adipose tissue energy expenditure and thermogenesis through stimulation of sympathetic nerve activity. Despite in vivo studies demonstrating a role for orexins acting centrally on adipose ti...

ea0029p1603 | Thyroid (non-cancer) | ICEECE2012

The T and B cell subsets in thyroids of children with Graves’ disease and Hashimoto’s thyroiditis

Ben-Skowronek I. , Szewczyk L. , Piekarski R. , Klatka M. , Korobowicz E.

Background: Autoimmune thyroid disorders (AITD) similar in pathomorphology picture results in hyper- or hypothyreosis. The differences between Graves’ disease (GD) and Hashimoto thyroiditis (HT) suggested that changes in the subsets of T-cells may have an influence on the course of this reaction.Methods: The study involved 90 children: 30 with GD, 30 with HT and the control group – 30 children. After thyroidectomy, standard histological examina...

ea0094p365 | Neuroendocrinology and Pituitary | SFEBES2023

Suboptimal treatment of acromegaly potentially leading to onset and progression of B cell lymphoma

Iacuaniello Davide , Majeed Waseem , Pathmanaban Omar , Roncaroli Federico , Kearney Tara

Acromegaly is a rare endocrine disorder mostly caused by a growth hormone (GH)-secreting pituitary adenoma. The aim of treatment is to normalize GH/IGF1 levels to limit disease burden. Growth hormone hypersecretion is associated with an increased cancer risk; cases of Acromegaly complicated by lymphoma have been reported. We share a clinical case characterized by suboptimal treatment, potentially leading to advancing orbital lymphoma. This 49-year-old man was diagnosed with Ac...

ea0049ep466 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Type B insulin resistance syndrome in a patient with connective tissue disease

Lebkowska Agnieszka , Krentowska Anna , Adamska Agnieszka , Piasecka Beata , Lipinska Danuta , Kowal-Bielecka Otylia , Semple Robert , Gorska Maria , Kowalska Irina

Introduction: Type B insulin resistance syndrome is an autoimmune disorder characterized by the production of autoantibodies against the insulin receptor. It leads to glucose metabolism disorders, extreme insulin resistance, hyperandrogenism and is associated with other features of autoimmunity.Case report: A 27-year-old man, with a 2-years history of psoriasis, was admitted to our Department because of loss of weight (20 kg in 1 year) and fatigue. He al...